PQA endorsed two new diabetes-focused health plan performance measures in December 2020. More than 34 million Americans have diabetes, according to the Centers for Disease Control and Prevention. These measures will help evaluate the quality of care for a disease that annually costs America $327 billion.

Ben Shirley, PQA's associate director of performance measurement, provides insights in this Q&A blog on the measures, the quality gaps they address, and PQA's work to develop pharmacy performance measures for diabetes.